ODonnell Kathleen M 4

4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed Sep 22, 2004

Form 4

Period: 2004-09-20

10% Owner

Transactions

Purchase
Common Stock
2004-09-21$3.00/sh+200$600→ 125,400 total(indirect: By Trust)
Purchase
Common Stock
2004-09-20$2.85/sh+2,500$7,124→ 120,000 total(indirect: By Trust)
Purchase
Common Stock
2004-09-21$3.00/sh+500$1,500→ 123,350 total(indirect: By Trust)
Purchase
Common Stock
2004-09-21$3.00/sh+50$150→ 123,400 total(indirect: By Trust)
Purchase
Common Stock
2004-09-21$3.00/sh+800$2,400→ 126,200 total(indirect: By Trust)
Purchase
Common Stock
2004-09-21$2.85/sh+100$285→ 122,600 total(indirect: By Trust)
Purchase
Common Stock
2004-09-21$2.98/sh+1,000$2,980→ 124,900 total(indirect: By Trust)
Purchase
Common Stock
2004-09-21$3.00/sh+1,200$3,600→ 127,400 total(indirect: By Trust)
Purchase
Common Stock
2004-09-21$2.85/sh+250$713→ 122,850 total(indirect: By Trust)

Holdings

Warrants
(indirect: By Trust)
Exercise: $6.30From: 2003-06-24Exp: 2007-06-24→ Common Stock (5,000 underlying)
35,000
Series B Convertible Preferred Stock
(indirect: By LLC)
From: 2006-03-31→ Common Stock (294,118 underlying)
294,118
Common Stock
(indirect: By LLC)
3,111,580
Common Stock
4,577

Footnotes (3)

[F1]Held by the Francis E. O'Donnell Irrevocable Trust #1, of which reporting party is Trustee
[F2]Held by Hopkins Capital Group II, LLC, which is one-third owned by the Francis E. O'Donnell Irrevocable Trust #1, of which reporting party is Trustee. The Series B Convertible Preferred Stock is convertible into shares of the Compan's common stock on a one for one basis.
[F3]Not Applicable

Documents

1 file